Budget Reconciliation Process Continues with Senate Consideration of Revised House Resolution

April 9, 2025

medicaid

On April 5, the Senate voted 51-48 to pass a modified version of the House-passed budget resolution with reduced deficit reduction targets for Senate committees as compared to the House. Specific to health care, the revised Senate resolution instructs the Senate Finance Committee (SFC), which has jurisdiction over Medicaid, to propose changes that will increase the deficit by no more than $1.5 trillion, but does not provide a target number for potential cuts.

The revised resolution maintains the cuts for House committees, including instructions to the Energy and Commerce Committee (E&C), which also has jurisdiction over Medicaid, to find at least $880 billion in savings over the next 10 years. In effect, if this version of the resolution passes both chambers, this gives Senate committees much more flexibility to roll back potential cuts that may be considered by the House, including potential Medicaid cuts. House Speaker Mike Johnson (R-LA) has stated large Medicaid program cuts, such as per capita caps and changes to the Federal Medical Assistance Percentage (FMAP), are no longer under consideration.

While there is no clarity into proposals being considered for cuts, a partial or full repeal of regulations promulgated by the Biden Administration including the nursing home staffing rule, the Medicaid/CHIP ACCESS rule, and the Medicaid Eligibility rule, could be on the table. The next step in the process is for the House to pass the revised resolution, which may be difficult given conservatives’ skepticism of the lack of certainty around budget cuts.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like